Middlebrook Revenue and Competitors
Estimated Revenue & Valuation
- Middlebrook's estimated annual revenue is currently $6.8M per year.
- Middlebrook's estimated revenue per employee is $201,000
Employee Data
- Middlebrook has 34 Employees.
- Middlebrook grew their employee count by -6% last year.
Middlebrook's People
| Name | Title | Email/Phone |
|---|
Middlebrook Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $26.7M | 133 | 20% | N/A | N/A |
#2 | $13.5M | 67 | 6% | N/A | N/A |
#3 | $16.1M | 80 | -2% | N/A | N/A |
#4 | $62.5M | 0 | N/A | N/A | N/A |
#5 | $10.1M | 50 | 6% | N/A | N/A |
#6 | $119.4M | 594 | 27% | N/A | N/A |
#7 | $22.9M | 114 | 8% | N/A | N/A |
#8 | $92.9M | 462 | 8% | N/A | N/A |
#9 | $11.3M | 56 | -8% | N/A | N/A |
#10 | $7M | 35 | 6% | N/A | N/A |
What Is Middlebrook?
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) (formerly Advancis) is a pharmaceutical company focused on developing and commercializing anti-infective products that fulfill unmet medical needs. MiddleBrook currently markets KEFLEX®, the immediate-release brand of cephalexin, and MOXATAG® – the first and only FDA-approved once-daily amoxicillin.
keywords:N/A
N/A
Total Funding
34
Number of Employees
$6.8M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Middlebrook News
... Earth Week happenings and top Easter brunch options; our special guest this week is the Mayor of South Lake Tahoe, Devin Middlebrook!
during the heavy rains on Thursday evening and struck electrical wires caused damage to the electrical panels at Cider Mill and Middlebrook...
Donna Middlebrook 1943 2022 JACKSONVILLE, Fla. Donna Middlebrook, 78, formally of Lisbon, Maine, died Sunday, March 27,...
Other Companies in Westlake
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 34 | 3% | N/A |
#2 | $3.9M | 34 | 0% | N/A |
#3 | $6.4M | 35 | 0% | N/A |
#4 | $9.2M | 35 | -3% | N/A |
#5 | $5M | 35 | 3% | N/A |